The latest news
about Abzu.
Read, watch, or listen to the most recent news about Abzu, including achievements with our explainable and reliable AI.
Press releases.
The latest news about Abzu, by Abzu.
Abzu wins Best HealthTech at the 2023 Nordic Startup Awards.
Abzu, the Danish / Spanish startup that has introduced new methods and technology to drive discoveries and reduce R&D costs for pharmaceutical and biotech companies, is thrilled to win Best HealthTech at the 2023 Nordic Startup Awards.
Abzu® and Contera Pharma expand strategic partnership to add target identification to RNA therapeutic design platform.
The application designs RNA therapeutics through parallel hypotheses testing of drug targets and individual antisense oligonucleotide (ASO) drug properties.
The U.S. Patent and Trademark Office issues patent for the technology behind the pioneering QLattice® algorithm.
Abzu® announced that the United States Patent and Trademark Office (USPTO) has issued Abzu Aps a patent number US 11,537,686 titled “Method of Deriving a Correlation” that protects the technology behind the pioneering QLattice algorithm.
News about Abzu.
We’re just a bunch of nice nerds building something new and awesome. We appreciate it when others notice.
Sifted
May 5, 2023
20 Nordic startups to watch, according to investors
Bootstrapping
April 17, 2023
Ugens startup: Abzu – I kamp mod cancer
The Org
Feb 15, 2023
How an AI Startup Built a Fully Transparent Organization with No Bosses
Zetland
Feb 9, 2023
Hvad vil du have i løn?
Awards and recognition.
We are thrilled and honored to be recognized for our explainable and reliable technology and unique organization.
2023 winner “Best HealthTech” Nordics
Nordic Ethical AI Landscape member
EIC Accelerator grant winner
2022 Gartner® Cool Vendor™
2022 1st place winner “Synthetic Track”
2022 2nd place winner “Real-world Track”
Abzu videos.
Abzoids speak about their passions, including explainable AI, entrepreneurship, and self-managing organizations.
Learn how explainable AI is enabling researchers to gain a deeper understanding of complex biological systems, uncover hidden patterns, and make more informed decisions.
Abzu’s Jonas Elsborg presents his research with NASA GeneLab: “Elucidating dermatological changes in spaceflight with explainable AI.”
The TOLAC project brings data-driven insights to expectant parents at important stages of pregnancy to reduce the risk inherent in vaginal or caesarian delivery.
Podcasts.
Listen to Abzoids speak about their passions.
An enlightening conversation with Marco Salvatore, the Head of Target & Biomarker Discovery at Abzu, a pioneer in the use of AI and ML in drug development.
Part 2 with Casper Wilstrup: Self-management, transparency, and a new kind of AI to revolutionize science.
Part 1 with Casper Wilstrup: The path to inventing a new kind of AI.
Subscribe for
notifications from Abzu.
